1. Home
  2. BKE vs RXRX Comparison

BKE vs RXRX Comparison

Compare BKE & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Buckle Inc. (The)

BKE

Buckle Inc. (The)

HOLD

Current Price

$50.60

Market Cap

2.5B

ML Signal

HOLD

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.56

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKE
RXRX
Founded
1948
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
1992
2021

Fundamental Metrics

Financial Performance
Metric
BKE
RXRX
Price
$50.60
$3.56
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$55.00
$7.50
AVG Volume (30 Days)
589.9K
21.6M
Earning Date
03-13-2026
02-27-2026
Dividend Yield
8.72%
N/A
EPS Growth
3.79
N/A
EPS
4.09
N/A
Revenue
$1,277,894,000.00
$43,689,000.00
Revenue This Year
$7.42
$6.74
Revenue Next Year
$2.75
$34.31
P/E Ratio
$12.35
N/A
Revenue Growth
4.67
N/A
52 Week Low
$33.12
$3.71
52 Week High
$61.69
$12.36

Technical Indicators

Market Signals
Indicator
BKE
RXRX
Relative Strength Index (RSI) 45.06 29.92
Support Level $46.59 $4.35
Resistance Level $49.49 $4.29
Average True Range (ATR) 1.76 0.28
MACD -0.02 -0.11
Stochastic Oscillator 43.66 0.88

Price Performance

Historical Comparison
BKE
RXRX

About BKE Buckle Inc. (The)

Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: